(Q45006616)
Statements
Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C (English)
Hiromitsu Kumada
Fumitaka Suzuki
Kenji Ikeda
Masahiro Kobayashi
Yoshiyuki Suzuki
Norio Akuta
Yasuji Arase
Satoshi Saitoh
Takashi Someya
Shintaro Takaki
Akihito Tsubota